MALO - Clinical Trial

¿Quién puede participar en el Estudio?

Grupo etario

Adultos

Detalles del Estudio

Título Completo

N1T-MC-MALO : A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01; N1T-MC-RT01

Investigador Principal